Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
Yen-Chung LinJheng-Wei LinMai-Szu WuKuan-Chou ChenChiung-Chi PengWen-Hsuan HouPublished in: PloS one (2017)
CCBs has similar effects on long term blood pressure, mortality, heart failure, stroke or cerebrovascular events, and renal function to RAAS blockades in patients CKD stage 3 to 5D and hypertension.
Keyphrases
- angiotensin converting enzyme
- chronic kidney disease
- end stage renal disease
- blood pressure
- angiotensin ii
- heart failure
- peritoneal dialysis
- hypertensive patients
- atrial fibrillation
- heart rate
- ejection fraction
- newly diagnosed
- risk factors
- cardiovascular disease
- left ventricular
- adipose tissue
- subarachnoid hemorrhage
- patient reported
- blood glucose
- cardiac resynchronization therapy
- blood brain barrier